An MRI-based radiomics nomogram to predict progression-free survival in patients with endometrial cancer.

IF 2.6 4区 医学 Q2 ONCOLOGY
Future oncology Pub Date : 2025-09-01 Epub Date: 2024-09-17 DOI:10.1080/14796694.2024.2398984
Ling Liu, Xiaodong Ji, Caihong Liang, Jinxia Zhu, Lixiang Huang, Yujiao Zhao, Xiangfeng Xu, Zhiyi Song, Wen Shen
{"title":"An MRI-based radiomics nomogram to predict progression-free survival in patients with endometrial cancer.","authors":"Ling Liu, Xiaodong Ji, Caihong Liang, Jinxia Zhu, Lixiang Huang, Yujiao Zhao, Xiangfeng Xu, Zhiyi Song, Wen Shen","doi":"10.1080/14796694.2024.2398984","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study aimed to explore the importance of an MRI-based radiomics nomogram in predicting the progression-free survival (PFS) of endometrial cancer.<b>Methods:</b> Based on clinicopathological and radiomic characteristics, we established three models (clinical, radiomics and combined model) and developed a nomogram for the combined model. The Kaplan-Meier method was utilized to evaluate the association between nomogram-based risk scores and PFS.<b>Results:</b> The nomogram had a strong predictive ability in calculating PFS with areas under the curve (ROC) of 0.905 and 0.901 at 1 and 3 years, respectively. The high-risk groups identified by the nomogram-based scores had shorter PFS compared with the low-risk groups.<b>Conclusion:</b> The radiomics nomogram has the potential to serve as a noninvasive imaging biomarker for predicting individual PFS of endometrial cancer.</p>","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":" ","pages":"2895-2909"},"PeriodicalIF":2.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2024.2398984","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study aimed to explore the importance of an MRI-based radiomics nomogram in predicting the progression-free survival (PFS) of endometrial cancer.Methods: Based on clinicopathological and radiomic characteristics, we established three models (clinical, radiomics and combined model) and developed a nomogram for the combined model. The Kaplan-Meier method was utilized to evaluate the association between nomogram-based risk scores and PFS.Results: The nomogram had a strong predictive ability in calculating PFS with areas under the curve (ROC) of 0.905 and 0.901 at 1 and 3 years, respectively. The high-risk groups identified by the nomogram-based scores had shorter PFS compared with the low-risk groups.Conclusion: The radiomics nomogram has the potential to serve as a noninvasive imaging biomarker for predicting individual PFS of endometrial cancer.

预测子宫内膜癌患者无进展生存期的核磁共振成像放射组学提名图。
目的:本研究旨在探讨基于核磁共振成像的放射组学提名图在预测子宫内膜癌无进展生存期(PFS)中的重要性:方法:根据临床病理和放射组学特征,我们建立了三种模型(临床模型、放射组学模型和综合模型),并为综合模型开发了一个提名图。采用 Kaplan-Meier 法评估基于提名图的风险评分与 PFS 之间的关系:结果:提名图在计算 PFS 方面具有很强的预测能力,1 年和 3 年的曲线下面积(ROC)分别为 0.905 和 0.901。根据提名图评分确定的高风险组与低风险组相比,PFS 更短:放射组学提名图有望成为预测子宫内膜癌个体PFS的无创影像生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Future oncology
Future oncology ONCOLOGY-
CiteScore
5.40
自引率
3.00%
发文量
335
审稿时长
4-8 weeks
期刊介绍: Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信